# Phase III Clinical Trial Evaluating the Efficacy and Safety of Ciprofol Injection for the Induction of Sedation/Anesthesia in Subjects Undergoing Gynecological Outpatient Surgeries

> **NCT04958746** · PHASE3 · COMPLETED · sponsor: **Haisco Pharmaceutical Group Co., Ltd.** · enrollment: 135 (actual)

## Conditions studied

- Gynecological Outpatient Surgery

## Interventions

- **DRUG:** Ciprofol
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT04958746
- **Lead sponsor:** Haisco Pharmaceutical Group Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-26
- **Primary completion:** 2021-09-29
- **Final completion:** 2021-09-30
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2022-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04958746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04958746, "Phase III Clinical Trial Evaluating the Efficacy and Safety of Ciprofol Injection for the Induction of Sedation/Anesthesia in Subjects Undergoing Gynecological Outpatient Surgeries". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04958746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*